NASDAQ: HOLXHologic Inc Stock Ownership - Who owns Hologic?
Insider buying vs selling
Have Hologic Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Scott T. Garrett | Director | 2024-03-14 | 16,441 | $75.50 | $1.24MSell |
| Scott T. Garrett | Director | 2024-03-14 | 7,402 | $36.04 | $266.77kBuy |
| Scott T. Garrett | Director | 2024-03-14 | 9,039 | $26.74 | $241.70kBuy |
| Sally Crawford | Director | 2024-03-08 | 9,039 | $76.40 | $690.61kSell |
| Sally Crawford | Director | 2024-03-08 | 9,039 | $26.74 | $241.70kBuy |
| Charles J. Dockendorff | Director | 2024-03-08 | 1,465 | $76.21 | $111.65kSell |
| Karleen Marie Oberton | Chief Financial Officer | 2024-01-29 | 14,940 | $75.00 | $1.12MSell |
| Charles J. Dockendorff | Director | 2024-01-02 | 16,017 | $72.00 | $1.15MSell |
| Charles J. Dockendorff | Director | 2024-01-02 | 7,551 | $38.44 | $290.26kBuy |
| Scott T. Garrett | Director | 2023-12-11 | 10,000 | $68.71 | $687.12kSell |
HOLX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when HOLX insiders and whales buy or sell their stock.
HOLX Shareholders
What type of owners hold Hologic Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Carl C. Icahn | 11.99% | 28,154,879 | $2.17B | Insider |
| Vanguard Group Inc | 11.79% | 27,679,701 | $2.14B | Institution |
| Blackrock Inc | 10.34% | 24,264,185 | $1.87B | Institution |
| T Rowe Price Investment Management Inc | 9.40% | 22,071,713 | $1.70B | Institution |
| State Street Corp | 4.73% | 11,104,181 | $857.13M | Institution |
| Geode Capital Management LLC | 2.38% | 5,581,010 | $430.80M | Institution |
| Victory Capital Management Inc | 2.15% | 5,055,048 | $390.20M | Institution |
| Macquarie Group Ltd | 1.81% | 4,236,966 | $327.05M | Institution |
| Renaissance Technologies LLC | 1.71% | 4,015,902 | $309.99M | Institution |
| Price T Rowe Associates Inc | 1.51% | 3,544,181 | $273.58M | Institution |
HOLX vs Medical Stocks
Hologic Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.